Mark D Bunting
38th Lorne Cancer Conference 2026
Days
Thursday, 12th February
Friday, 13th February
Saturday, 14th February
Search
Speakers
Mark D Bunting
Abstracts this author is presenting:
Dysregulation of the tristetraprolin and NF-kappa B pathway contributes to estrogen receptor positive breast cancer treatment resistance.
—
Welcome Reception & Poster Session 1